Financial Incentives to Translate ALLHAT into Practice
将 ALLHAT 转化为实践的经济激励
基本信息
- 批准号:7458181
- 负责人:
- 金额:$ 13.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-09-01 至 2012-05-31
- 项目状态:已结题
- 来源:
- 关键词:AdministratorAdoptedAntihypertensive AgentsAwarenessBehaviorBlood PressureCaringClinicalClinical ResearchClinical TrialsConditionCongestive Heart FailureCoronary ArteriosclerosisCost ControlCosts and BenefitsCoupledDetectionDiseaseEvaluationFeedbackGoalsGuidelinesHealthHealth ServicesHealthcareHigh Blood PressureHospitalsHypertensionIncentivesIndividualInstitute of Medicine (U.S.)InterventionJointsJournalsKidney FailureKnowledgeLDL Cholesterol LipoproteinsLeadLipidsMeasuresMedicareMethodsMyocardial InfarctionNew EnglandOutpatientsPatient CarePatientsPerformancePeripheral arterial diseasePharmacologic SubstancePhysiciansPolicy MakerPreventionPrimary Care PhysicianPrimary Health CarePublic HealthQuality of CareRandomizedRandomized Controlled Clinical TrialsRandomized Controlled TrialsReportingResearchResearch PersonnelRewardsState MedicineStrokeSystemTestingThiazide DiureticsTimeTranslatingTranslationsUpper armbeneficiaryblood pressure regulationclinically relevantcostcost effectivenesseditorialhealth care deliveryhealth care modelhypertension treatmentimprovedneglectpaymentpreventprograms
项目摘要
Despite compelling evidence of the benefits of treatment, hypertension is controlled in less than one-quarter
of US citizens. Inadequate blood pressure control results in excess cases of coronary artery disease,
congestive heart failure, stroke and other diseases. While some of the reasons for poor blood pressure
control are due to poor compliance on the part of patients, there is significant under-treatment of
hypertension on the part of physicians. In one recent study, people with hypertension received less than
65% of recommended care. Translation of scientific knowledge from trials such as the Antihypertensive
and Lipid Lowering Treatment to Prevent Heart Attack Trial [ALLHATJ into clinical practice and improved
health for patients is lagging. Heightened awareness of =bottlenecks" in the translation of research
knowledge into clinical practice has raised enthusiasm about using creative methods, including financial
incentives, to improve translation. Indeed, pharmaceutical companies have been using financial incentives
to change physician behavior for decades. Using a randomized controlled trial, we will test the effect of
explicit physician-level financial incentives to promote translation of findings from the ALLHAT trial into
clinical practice and improved control of hypertension in the primary care setting. A total of 130 primary
care physicians will be randomized to two study arms: 1) physician-level financial incentive only + audit and
feedback; and 2) audit and feedback only. Use of thiazide diuretics among eligible patients according to the
ALLHAT study criteria and the proportion of patients achieving goal blood pressure according to the
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of
High Blood Pressure goal will be the pdmary dependent variables. We will use analytic methods
appropriate for a cluster-randomized trial, as patients are nested within physicians, who are further nested
in hospitals. We will assess whether financial incentives are a cost-effective intervention. Findings from
this study will provide critical information needed to implement methods of "paying for performance" and will
be directly applicable to such programs for the 40.5 million Medicare beneficiaries and the more than 18
million individuals cared for in staff-model health care delivery systems.
尽管有令人信服的证据表明治疗的益处,但高血压在不到四分之一的时间内得到了控制
美国公民。血压控制不足会导致冠状动脉疾病病例增多,
充血性心力衰竭、中风等疾病。虽然血压不佳的一些原因
由于患者依从性差,治疗不足的情况严重
医生的高血压。在最近的一项研究中,高血压患者接受的治疗少于
65% 的建议护理。抗高血压试验等科学知识的翻译
和降脂治疗预防心脏病试验[ALLHATJ进入临床实践并改进
患者的健康状况滞后。提高对研究翻译中的“瓶颈”的认识
将知识融入临床实践激发了人们使用创造性方法的热情,包括财务方法
激励措施,以改进翻译。事实上,制药公司一直在使用财务激励措施
改变几十年来医生的行为。我们将使用随机对照试验来测试效果
明确的医生层面的经济激励措施,以促进将 ALLHAT 试验的结果转化为
临床实践和改善初级保健机构高血压的控制。小学一共有130个
护理医生将被随机分配到两个研究组:1)仅医生级别的经济激励+审计和
反馈; 2) 仅审核和反馈。根据《符合条件的患者使用噻嗪类利尿剂》
ALLHAT 研究标准和达到目标血压的患者比例
全国预防、检测、评估和治疗联合委员会第七次报告
高血压目标将是主要因变量。我们将使用分析方法
适合整群随机试验,因为患者嵌套在医生中,而医生又进一步嵌套
在医院。我们将评估财政激励措施是否是一种具有成本效益的干预措施。调查结果来自
这项研究将提供实施“按绩效付费”方法所需的关键信息,并将
直接适用于 4050 万医疗保险受益人和超过 18 名医疗保险受益人的此类计划
数百万人在员工模式的医疗保健服务系统中得到照顾。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LAURA A PETERSEN其他文献
LAURA A PETERSEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LAURA A PETERSEN', 18)}}的其他基金
Medicaid Expansion and Quality, Utilization and Coordination of Health Care for Veterans with Chronic Kidney Disease
慢性肾病退伍军人医疗补助的扩展以及医疗保健的质量、利用和协调
- 批准号:
10335803 - 财政年份:2021
- 资助金额:
$ 13.48万 - 项目类别:
Medicaid Expansion and Quality, Utilization and Coordination of Health Care for Veterans with Chronic Kidney Disease
慢性肾病退伍军人医疗补助的扩展以及医疗保健的质量、利用和协调
- 批准号:
10833998 - 财政年份:2021
- 资助金额:
$ 13.48万 - 项目类别:
Improving the Measurement of VA Facility Performance to Foster a Learning Healthcare System
改进对 VA 设施绩效的衡量,以培育学习型医疗保健系统
- 批准号:
10186492 - 财政年份:2017
- 资助金额:
$ 13.48万 - 项目类别:
Improving the Measurement of VA Facility Performance to Foster a Learning Healthcare System
改进对 VA 设施绩效的衡量,以培育学习型医疗保健系统
- 批准号:
9902190 - 财政年份:2017
- 资助金额:
$ 13.48万 - 项目类别:
Improving the Measurement of VA Facility Performance to Foster a Learning Healthcare System
改进对 VA 设施绩效的衡量,以培育学习型医疗保健系统
- 批准号:
9287114 - 财政年份:2017
- 资助金额:
$ 13.48万 - 项目类别:
Improving the Measurement of VA Facility Performance to Foster a Learning Healthcare System
改进对 VA 设施绩效的衡量,以培育学习型医疗保健系统
- 批准号:
9904156 - 财政年份:2017
- 资助金额:
$ 13.48万 - 项目类别:
Financial Incentives to Translate ALLHAT into Practice
将 ALLHAT 转化为实践的经济激励
- 批准号:
7845807 - 财政年份:2009
- 资助金额:
$ 13.48万 - 项目类别:
Financial Incentives to Translate ALLHAT into Practice
将 ALLHAT 转化为实践的经济激励
- 批准号:
7117716 - 财政年份:2005
- 资助金额:
$ 13.48万 - 项目类别:
Financial Incentives to Translate ALLHAT into Practice
将 ALLHAT 转化为实践的经济激励
- 批准号:
6858318 - 财政年份:2005
- 资助金额:
$ 13.48万 - 项目类别:
Financial Incentives to Translate ALLHAT into Practice
将 ALLHAT 转化为实践的经济激励
- 批准号:
7249439 - 财政年份:2005
- 资助金额:
$ 13.48万 - 项目类别:
相似国自然基金
锶银离子缓释钛表面通过线粒体自噬调控NLRP3炎症小体活化水平促进骨整合的机制研究
- 批准号:82301139
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
万寿菊黄酮通过MAPK/Nrf2-ARE通路缓解肉鸡肠道氧化应激损伤的作用机制
- 批准号:32302787
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肠道菌群及其代谢产物通过mRNA m6A修饰调控猪肉品质的机制研究
- 批准号:32330098
- 批准年份:2023
- 资助金额:220 万元
- 项目类别:重点项目
PUFAs通过SREBPs提高凡纳滨对虾低盐适应能力的机制研究
- 批准号:32303021
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
EGLN3羟化酶通过调控巨噬细胞重编程促进肺癌细胞EMT及转移的机制研究
- 批准号:82373030
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Remote Monitoring and Virtual Collaborative Care for Hypertension Control to Prevent Cognitive Decline
远程监控和虚拟协作护理控制高血压以防止认知能力下降
- 批准号:
10451202 - 财政年份:2020
- 资助金额:
$ 13.48万 - 项目类别:
Remote Monitoring and Virtual Collaborative Care for Hypertension Control to Prevent Cognitive Decline
远程监控和虚拟协作护理控制高血压以防止认知能力下降
- 批准号:
10045856 - 财政年份:2020
- 资助金额:
$ 13.48万 - 项目类别:
Remote Monitoring and Virtual Collaborative Care for Hypertension Control to Prevent Cognitive Decline
远程监控和虚拟协作护理控制高血压以防止认知能力下降
- 批准号:
10468992 - 财政年份:2020
- 资助金额:
$ 13.48万 - 项目类别:
Remote Monitoring and Virtual Collaborative Care for Hypertension Control to Prevent Cognitive Decline
远程监控和虚拟协作护理控制高血压以防止认知能力下降
- 批准号:
10693852 - 财政年份:2020
- 资助金额:
$ 13.48万 - 项目类别:
Implementing a Multicomponent Intervention to Improve Hypertension Control in Central America
实施多成分干预措施以改善中美洲的高血压控制
- 批准号:
10220115 - 财政年份:2017
- 资助金额:
$ 13.48万 - 项目类别: